- gsearch

- gsearch

CDC Stacks Public Health Publications

Search Results

Narrow Results:
Publication Year
Medical Subject
Personal Author
Place as Subject
Resource Type General
HHSN261201300015C/RC/CCR NIH HHS/United States
  • Chemotherapy Decisions and Patient Experience with the Recurrence Score Assay for EarlyStage Breast Cancer
    Chemotherapy Decisions and Patient Experience with the Recurrence Score Assay for Early-Stage Breast Cancer
    :
    :
  • Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer
    Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer
    :
    :
  • The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance epidemiology and end results registry program
    The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program
    :
    :
  • Contralateral Prophylactic Mastectomy Decisions in a PopulationBased Sample of Patients with EarlyStage Breast Cancer
    Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients with Early-Stage Breast Cancer
    :
    :
  • Understanding the Engagement of Key Decision Support Persons in Patient Decision Making Around Breast Cancer Treatment
    Understanding the Engagement of Key Decision Support Persons in Patient Decision Making Around Breast Cancer Treatment
    :
    :
  • The association between patient attitudes and values with strength of consideration for contralateral prophylactic mastectomy in a populationbased sample of breast cancer patients
    The association between patient attitudes and values with strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients
    :
    :
  • What factors influence womens perceptions of their systemic recurrence risk after breast cancer treatment
    What factors influence women’s perceptions of their systemic recurrence risk after breast cancer treatment?
    :
    :
  • Oncologists influence on receipt of adjuvant chemotherapy Does it matter whom you see for treatment of curable breast cancer
    Oncologists’ influence on receipt of adjuvant chemotherapy: Does it matter whom you see for treatment of curable breast cancer?
    :
    :
  • Genetic testing and counseling among patients with newly diagnosed breast cancer
    Genetic testing and counseling among patients with newly diagnosed breast cancer
    :
    No Description
  • Treatment Experiences of Latinas After Diagnosis Of Breast Cancer
    Treatment Experiences of Latinas After Diagnosis Of Breast Cancer
    :
    :
  • Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer
    Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer
    :
    :
  • The Impact of DoctorPatient Communication on Patients Perceptions of their Risk of Breast Cancer Recurrence
    The Impact of Doctor-Patient Communication on Patients’ Perceptions of their Risk of Breast Cancer Recurrence
    :
    :
  • The influence of 21gene recurrence score assay on chemotherapy use in a populationbased sample of breast cancer patients
    The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients
    :
    :
  • Recurrence Risk Perception and Quality of Life Following Treatment of Breast Cancer
    Recurrence Risk Perception and Quality of Life Following Treatment of Breast Cancer
    :
    :
  • TreatmentAssociated Toxicities Reported by Patients with EarlyStage Invasive Breast Cancer
    Treatment-Associated Toxicities Reported by Patients with Early-Stage Invasive Breast Cancer
    :
    :